| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy, 1-382, 2021 | 7142 | 2021 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ... Autophagy 4 (2), 151-175, 2008 | 2488 | 2008 |
| Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer JA Locke, ES Guns, AA Lubik, HH Adomat, SC Hendy, CA Wood, ... Cancer research 68 (15), 6407-6415, 2008 | 813 | 2008 |
| Cumulative association of five genetic variants with prostate cancer SL Zheng, J Sun, F Wiklund, S Smith, P Stattin, G Li, HO Adami, FC Hsu, ... New England Journal of Medicine 358 (9), 910-919, 2008 | 687 | 2008 |
| Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development M Gironella, M Seux, MJ Xie, C Cano, R Tomasini, J Gommeaux, S Garcia, ... Proceedings of the National Academy of Sciences 104 (41), 16170-16175, 2007 | 625 | 2007 |
| Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ... Cancer discovery 1 (6), 487-495, 2011 | 602 | 2011 |
| Intraprostatic androgens and androgen-regulated gene expression persist after testosterone suppression: therapeutic implications for castration-resistant prostate cancer EA Mostaghel, ST Page, DW Lin, L Fazli, IM Coleman, LD True, ... Cancer research 67 (10), 5033-5041, 2007 | 568 | 2007 |
| Derivation of androgen‐independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells HC Wu, JT Hsieh, ME Gleave, NM Brown, S Pathak, LWK Chung International journal of cancer 57 (3), 406-412, 1994 | 555 | 1994 |
| Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts M Gleave, JT Hsieh, C Gao, AC Von Eschenbach, LWK Chung Cancer research 51 (14), 3753-3761, 1991 | 537 | 1991 |
| The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ... The EMBO journal 30 (13), 2719-2733, 2011 | 485 | 2011 |
| Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ... European urology 73 (2), 178-211, 2018 | 453* | 2018 |
| Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells DJ Mulholland, N Kobayashi, M Ruscetti, A Zhi, LM Tran, J Huang, ... Cancer research 72 (7), 1878-1889, 2012 | 441 | 2012 |
| Active surveillance of small renal masses: progression patterns of early stage kidney cancer MAS Jewett, K Mattar, J Basiuk, CG Morash, SE Pautler, DR Siemens, ... European urology 60 (1), 39-44, 2011 | 419 | 2011 |
| Antisense therapy for cancer ME Gleave, BP Monia Nature Reviews Cancer 5 (6), 468-479, 2005 | 391 | 2005 |
| Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report SL Goldenberg, N Bruchovsky, ME Gleave, LD Sullivan, K Akakura Urology 45 (5), 839-845, 1995 | 361 | 1995 |
| Androgen receptor gene aberrations in circulating cell-free DNA: biomarkers of therapeutic resistance in castration-resistant prostate cancer AA Azad, SV Volik, AW Wyatt, A Haegert, S Le Bihan, RH Bell, ... Clinical cancer research 21 (10), 2315-2324, 2015 | 359 | 2015 |
| Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer P Rocchi, A So, S Kojima, M Signaevsky, E Beraldi, L Fazli, ... Cancer research 64 (18), 6595-6602, 2004 | 347 | 2004 |
| Interferon gamma-1b compared with placebo in metastatic renal-cell carcinoma ME Gleave, M Elhilali, Y Fradet, I Davis, P Venner, F Saad, LH Klotz, ... New England Journal of Medicine 338 (18), 1265-1271, 1998 | 332 | 1998 |
| Randomized comparative study of 3 versus 8-month neoadjuvant hormonal therapy before radical prostatectomy: biochemical and pathological effects ME GLEAVE, SL GOLDENBERG, JL CHIN, J WARNER, F SAAD, ... The Journal of urology 166 (2), 500-507, 2001 | 325 | 2001 |
| Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance H Tanaka, E Kono, CP Tran, H Miyazaki, J Yamashiro, T Shimomura, ... Nature medicine 16 (12), 1414-1420, 2010 | 318 | 2010 |
